Related Experiment Videos

Penicillin-binding protein 2b of Streptococcus pneumoniae in piperacillin-resistant laboratory mutants

R Hakenbeck1, C Martin, C Dowson

  • 1Max-Planck Institut für Molekulare Genetik, Berlin, Germany.

Journal of Bacteriology
|September 1, 1994
PubMed

Insights

Mutations in penicillin-binding protein 2b (PBP 2b) drive piperacillin resistance in Streptococcus pneumoniae. Specific point mutations in PBP 2b alter antibiotic binding, contributing to beta-lactam resistance development.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Antibiotic Resistance

Background:

  • Beta-lactam antibiotics, including piperacillin, are crucial for treating Streptococcus pneumoniae infections.
  • Development of resistance in S. pneumoniae is often linked to alterations in penicillin-binding proteins (PBPs).
  • Penicillin-binding protein 2b (PBP 2b) is implicated in reduced affinity for penicillin, a key factor in resistance.

Purpose of the Study:

  • To investigate the genetic basis of piperacillin resistance in Streptococcus pneumoniae.
  • To characterize the specific mutations in PBP 2b responsible for acquired resistance.
  • To compare resistance mechanisms with those observed for other beta-lactams.

Main Methods:

  • Isolation and characterization of three independent piperacillin-resistant laboratory mutants of S. pneumoniae.
  • Genetic analysis to identify point mutations within the PBP 2b gene.
  • Determination of the specific amino acid substitutions resulting from these mutations.

Main Results:

  • Each resistant mutant possessed a single point mutation in the PBP 2b gene.
  • Identified mutations included Gly-617 to Ala and Gly-to-Asp substitutions in critical regions of PBP 2b.
  • These altered sites are homologous to those previously identified in PBP 2x associated with cefotaxime resistance.

Conclusions:

  • Single point mutations in PBP 2b are sufficient to confer piperacillin resistance in S. pneumoniae.
  • Specific amino acid changes in PBP 2b directly impact its interaction with beta-lactam antibiotics.
  • Similar mutation sites in different PBPs (PBP 2b and PBP 2x) suggest conserved mechanisms of beta-lactam interaction and resistance.

Related Concept Videos